Thursday, 22 February 2024


Global CRO Tigermed opens international headquarters in Hong Kong

18 August 2023 | News

To coordinate and manage global projects more efficiently

Image credit: prnewswire

Image credit: prnewswire

Tigermed, a leading global Contract Research Organisation (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, has officially announced the opening of its International Headquarters in Hong Kong, marking an important step forward on the path of global operation and corporate development.

The International Headquarters will enable Tigermed to coordinate and manage global projects more efficiently, drive business expansion, and empower customers on a global scale. Besides, it will bring new energy to the company's service platform, global talent, supporting functions, corporate culture, and beyond.  

As a prominent financial hub in the Asian-Pacific region, Hong Kong holds a significant position in the global healthcare sector with a competitive business environment and excellent culture of innovation.

With the support from Hong Kong Innovation, Technology, and Industry Bureau (ITIB), the Office for Attracting Strategic Enterprises (OASES), and various stakeholders across the industry, Tigermed International Headquarters was established with high efficiency and is now ready to impact greater clinical development landscape in the region.  

Going forward, Tigermed will collaborate with more global innovative enterprises and research institutions, and provide high-quality CRO services for the pharmaceutical and medical device industries. With its extensive project experience and comprehensive technology platform, Tigermed will strive to bring in global innovative projects to create a robust R&D system. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account